Sperm protein 17 targeting for epithelialovarian cancer treatment in the eraof modern immunoengineering

Due to the vague symptomatology of the disease and a lack of effective screening methods, most patients with epithelial ovarian cancer (EOC) present late in their disease. Despite advances in chemotherapeutic agents, the prognosis of these patients has uniformly been extremely poor. Although cisplat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Poplawska, Dibyendu Dutta, Yichun Lee, Seah H. Lim
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/1de7433646694abab8d081d7b30f2008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!